[HTML][HTML] Toward gene therapy for congenital thrombotic thrombocytopenic purpura
C Dekimpe, E Roose, K Sakai, C Tersteeg… - Journal of Thrombosis …, 2023 - Elsevier
Congenital thrombotic thrombocytopenic purpura (cTTP) is caused by a severe deficiency in
the plasma metalloprotease ADAMTS-13. The current management of cTTP is dependent on …
the plasma metalloprotease ADAMTS-13. The current management of cTTP is dependent on …
[HTML][HTML] Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura
HT Özpolat, M Stolla - Blood Transfusion, 2023 - ncbi.nlm.nih.gov
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder caused by a
deficiency of a disintegrin and metalloproteinase with a thrombospondin type 1 motif …
deficiency of a disintegrin and metalloproteinase with a thrombospondin type 1 motif …
Big in Japan: HLA-DRB1∗ 08: 03 and immune thrombotic thrombocytopenic purpura
J Voorberg, T Arfman, B Maillere - Journal of Thrombosis and …, 2023 - jthjournal.org
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder of
sudden onset that presents with thrombocytopenia, microangiopathic hemolytic anemia, and …
sudden onset that presents with thrombocytopenia, microangiopathic hemolytic anemia, and …